Advertisement

Topics

Stallergenes Greer Company Profile

01:16 EDT 17th June 2019 | BioPortfolio


News Articles [18 Associated News Articles listed on BioPortfolio]

Stallergenes Greer Confirms Appointments to the Board of Directors

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181212005535/en/ Stallergenes Greer (Paris:STAGR), a biopharmaceutical...

Stallergenes Greer Updates on the ANSM Injunction - Antony Site (France)

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190419005094/en/ Stallergenes Greer (Euronext:STAGR), a biopharmaceuti...

Recommended Cash Acquisition of Stallergenes Greer plc ("Stallergenes Greer") by Ares Life Sciences I S.à r.l. ("Waypoint")

Publication of the Scheme Document Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190405005205/en/ NOT FOR RELEASE, P...

Ares Life Sciences to take Stallergenes Greer private

Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy ...

Read more...

Stallergenes Greer to be taken private as it looks to overcome recent "operational challenges" https://www.firstwordpharma.com/node/1630743  $STAGR

Stallergenes Greer to be taken private as it looks to overcome recent "operational challenges" https://www.firstwordpharma.com/node/1630743  $STAGR

Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet STAGR320 to Treat House Dust Mite-Induced Allergic Rhinitis Achieved Its Primary Endpoint

The study achieved its primary efficacy endpoint (p<0.0001) The study also achieved all key secondary endpoints, and showed a comparable safety profil...

Stallergenes Greer's Delisting To Focus Leadership On Facility Issues

The acquisition of the UK-headquartered leading allergy immunotherapy firm by its private majority shareholder is expected to remove the distraction...  

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Allergenic extracts standardized mite [greer laboratories, inc.]

These highlights do not include all the information needed to use Greer Standardized Mite Extracts safely and effectively. See full prescribing information for Greer Standardized Mite Extracts.Standar...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Follow up of Ventilatory Function in Infant After Bronchiolitis During the First Year of Life

A significant proportion of asthma is diagnosed during childhood. Bronchiolitis is the most common lower respiratory tract illness (LRI) in early life and the present work is a prospective...

Companies [7 Associated Companies listed on BioPortfolio]

Stallergenes Greer

Stallergenes Greer plc

Greer

Greer is a leading developer and provider of allergy immunotherapy products and services for treating humans and animals. Greer’s scientists provide technical support for cus...

Stallergenes

For 50 years, Stallergenes specialist treatment of severe respiratory allergies by allergen immunotherapy, has set itself the objective, alongside health professionals to advance the treatment of se...

GREER Laboratories, Inc.

More Information about "Stallergenes Greer" on BioPortfolio

We have published hundreds of Stallergenes Greer news stories on BioPortfolio along with dozens of Stallergenes Greer Clinical Trials and PubMed Articles about Stallergenes Greer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stallergenes Greer Companies in our database. You can also find out about relevant Stallergenes Greer Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record